Аджибадем Сити Клиник

Acibadem City Clinic is one of the largest group of medical facilities in Bulgaria with a leading role in the provision of medical services in almost all areas of medicine.

Established in 2016, the Group is an association of the leaders in hospital health in the country - Tokuda Hospital and City Clinic - with the majority participation of one of Turkey's largest health holdings - Acibadem. The structure comprises 2 hospitals in Sofia, one of which has two hospital bases, two diagnostic-consultative centers and one Medical Center in Varna.

Acibadem City Clinic University Hospital Cardiovascular Center and Acibadem City Clinic University hospital Mladost are the only medical facilities in Bulgaria accredited under the international standard for quality and safety in healthcare - Joint Commission International (JCI).

We unite our efforts to offer you a new model of complex care

The healthcare group is distinguished by modern technological equipment, unique for the medical services in our country and innovative techniques for diagnosis, treatment and prevention, emergencies and health care in almost all medical fields.

The main mission of Acibadem City Clinic is to unite our efforts to offer the most comprehensive care for your health by proven specialists with the help of modern methods and the latest technologies of modern medicine.

The medical facilities of the Acibadem City Clinic group in Bulgaria are part of the international organization IHH Healthcare Berhad and their brand Acibadem, based in Turkey.

The medical establishments from the group of Acibadem City Clinic in Bulgaria are part of the international organization IHH Healthcare Berhad and their brand Acibadem, based in Turkey.

IHH Healthcare Berhad is a private premium healthcare provider operating in the markets of Malaysia and Singapore, leader in providing high quality medical services and the largest private healthcare group in Asia.

The organization headquarter is in Kuala Lumpur, and its activities are focused on the private hospital and health sector in Asia, Central and Eastern Europe, North Africa and the Middle East, with a strong presence in Singapore, Brunei, China, Hong Kong, Malaysia, Turkey, India , USA and United Arab Emirates. The group is among the leading medical suppliers in the domestic markets of Malaysia, Singapore, Turkey and India, and has a growing presence in China and an expanding network across Asia and Central and Eastern Europe.

IHH's business strategy has been clear from the outset - operating in markets where the demand for quality healthcare is growing rapidly especially where there are increasingly affluent and rapidly ageing populations. We continue to respond to the opportunities presented by the burgeoning medical travel sector, investing in facilities distinguished by their ability to meet the changing needs and demographics of the communities they serve.

The Group's portfolio comprise of premium-brand healthcare assets, collectively representing a unique multi-market investment position in the healthcare sector. Part of the group's brands are "Mount Elizabeth", "Gleneagles", "Pantai", "Parkway", "Acibadem" and "Fortis", which are among the most prestigious in Asia and Central and Eastern Europe.

IHH is a majority shareholder in Acıbadem Healthcare Group. Acıbadem is Turkey's largest private healthcare company. It consists of 21 hospitals and 16 medical centers, making the organization the second largest health chain in the world with this agreement under the auspices of IHH Healthcare Berhad.

In Bulgaria, the group owns four medical institutions under the name Acibadem City Clinic - Tokuda Hospital, Cardiovascular Center, Mladost, Medical Center Varna.

As part of this global family, the Acibadem City Clinic hospitals share knowledge and exchange experiences in all areas of medicine. This makes it possible to treat many diseases, for some of which there is no other alternative in Bulgaria. The staff of the medical establishments is constantly trained in innovative procedures and uses the latest achievements of medical science, using a global resource of knowledge and expertise.

The global family of IHH Healthcare Berhad provides access to resources that Acibadem City Clinic specialists transform into opportunities for patients - better treatment, high quality health care, innovative methods of diagnosis and therapy, world-class medical care and expertise.

Two of the hospitals in the group - Acibadem City Clinic Cardiovascular Center and Acibadem City Clinic Mladost are the only medical institutions in the country certified according to the international standard for quality and safety in the provision of medical services - JCI (Joint Commission International). International quality standards implemented in medical institutions guarantee a high level of medical services in all areas.

The main mission of Acibadem City Clinic is to offer comprehensive care to its patients through established specialists using modern methods and the latest technologies of modern medicine. The health model that the chain of medical institutions has built encompasses complete complex treatment solutions, with a focus on the multidisciplinary view of each disease. The leading values of the medical institutions from the Acibadem City Clinic group are Quality, Cooperation, Integrity, Compassion, Care.

2020
JCI Reaccreditation of Acibadem City Clinic UMBAL
2016
Merger of Hospital Tokuda, City Clinic and Acibadem
2015
Obtaining the status of a University Hospital, Acquisition of City Clinic Burgas , Opening of City Clinic Mladost
2014
Agreement with MD Andreson, JCI Accreditation
2013
Agreement with Partners Healthcare
2012
Opening of City Clinic Cardiovascular center
2011
Acquisition of City Clinic Varna
2010
City Clinic Opening
2006
Tokuda Hospital Opening

Acibadem City Clinic has two centers for clinical trials - Tokuda Hospital and University Hospital. The centers provide high quality services for the effective and ethical conduct of the clinical trials. They organize, coordinate and support the conduct of single-center and multi-center phase I, II, III and IV clinical trials, non-interventional trials, medical research and make contact with clinical trial sponsors, principal investigators, patients and the Committee for Preliminary Control of the Clinical Trials/Studies (CPCCT/S).

Clinical Trials Centers help researchers conduct safe, controlled, inpatient and outpatient trials by providing the necessary facilities and services.

Bases:

Administrative offices
Fully equipped doctor's office, incl. manipulation rooms
Research/monitoring rooms equipped with computers with internet access, fax and copy machines
Warehouse for storage of the tested products at the required temperatures

Administrative and regulatory activity:

Fast handling of feasibility questionnaires and initial documents. Overall project coordination
Support for the gathering of documents needed for submission to Bulgaria Drug Agency and Ethics Committee
Review and coordination of the contracts of the Hospital/Medical Center and Principal Investigators
Protocol review – analyze schedule of activities and procedures
Budget development
Provide coordinators for the clinical trials
Training of coordinators
Support for all visits – site selection visit, initiation visit, monitoring visit, close out visit etc.
Ensure appropriate conditions for the storage of the documentation and researched products and/or medical devices in accordance with the Good Clinical Practice (GCP) and Sponsors’ requirements
In contact with all the departments and laboratories

General Patient Information

Definition of a Clinical Trial

Before a new medicine can be released on the market it should pass through various clinical trials. These trials prove its quality, safety and efficiency.

Before conducting a clinical trial, it should be approved and authorized by the health authorities and regulatory organs – they decide if the patients’ rights are protected, if the trial is safe for the patients’ health and what will be the outcome for the patients.

Before a volunteer or a patient enters in a clinical trial he/she should receive documents that explain everything about the given clinical trial, so-called Informed consent. The Informed consent contains the purpose of the trial, its duration, therapy, procedures, potential benefits, risks etc. Each patient should read and sign personally the Informed consent before being enrolled in a clinical trial.

The clinical trials are conducted by highly qualified and trained medical people – investigators and coordinators. All investigators and coordinators follow strict rules, regulations and laws. The guidelines for the clinical trials are called Good Clinical Practice (GCP). GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected.

Clinical Trial Phases

Phase I – “First-in-humans” - drug is tested on a small group of people, very often healthy volunteers. It observes the effect of the drug on the human body, namely what happens when the drug dissolves in the body and how the drug reacts. The primary goal is to determine the appropriate dosing, safety and tolerability. Whenever the drug is determined to be safe enough, it can be tested in phase II clinical trial to check for efficiency. Usually up to 20 people are enrolled in Phase I clinical trials.

Phase II – The studies drug is administered to patients. The efficiency, optimal dose and safety of the drug are determined. The potential differences in pharmacokinetic behavior between healthy volunteers and patients is also studied. Several hundred patients are enrolled. Sometimes different treatments are combined and explored in this phase. If the drug has a good enough effect, it can be tested on a larger group of patients in Phase III.

Phase III – the aim is to study the safety and comparative effectiveness of the product. Up to several thousand patients are included. In this phase are compared therapies with standard-of-care or placebo to demonstrate whether the new drug has a better effect than its alternatives.

Phase IV – This phase takes place after the medicine has been licensed. The main points are to follow if there are any more side effects, to prove the safety of the drug, to precise the long term risk and the benefits from the treatment.

Safety

Ensuring the safety of volunteers and patients is with great importance during a clinical trial.

Benefits

Free, innovative and high quality treatments
Opportunity for better and more effective treatment than the existing ones
More frequent consultations and follow-up with the same team of doctors
Early access to new treatments
Help other people who will receive the treatment later on when the trial passes all the phases and improvements

Risks

The clinical trial may require more time, visits to hospital and even hospitalization
There might be side effects
The introduced strict regulations minimize the risk

*All the information about the patents is in the Informed consent and all benefits and risks should be discussed beforehand with your doctor

Submission of documents

Information for the procedure of submitting documents for conducting a clinical trial can be obtained as follows:

For Acibadem City Clinic Tokuda Hospital

phone +359 2 403 48 38

address: 51B Nikola Vaptsarov Blvd., Sofia 1407

For Acibadem City Clinic University Hospital

phone +359 895 584 044, contact person: Mimi Serafimova

address: 53 Nikola Vaptsarov Blvd., Sofia 1407

Acibadem City Clinic’s medical facilities have a year-round active fundraising campaign to support the doctors and the activities of the hospitals. The donated funds will be used for the purchase of technical equipment, consumables and equipment for the medical staff and the medical institutions.

United in the care for you

We unite our efforts to offer you a new model of complex care

IHH Healthcare and Acibadem

The medical establishments from the group of Acibadem City Clinic in Bulgaria are part of the international organization IHH Healthcare Berhad and their brand Acibadem, based in Turkey.

History

Management team

Awards

Clinical trials

Donate

We unite our efforts to offer you a new model of complex care

The medical establishments from the group of Acibadem City Clinic in Bulgaria are part of the international organization IHH Healthcare Berhad and their brand Acibadem, based in Turkey.

History

Acibadem City Clinic Tokuda Hospital

Acibadem City Clinic Cardiovascular center

Acibadem City Clinic Mladost

Acibadem City Clinic Medical center Varna